Close this search box.
Subscriber Log In
Webinar | On demand

Illiquid Gold: Creative Dealmaking in Biotech

Cem Baydar and Paul Verdin from Evaluate are joined by Ali Pashazadeh, Max Baumann, and Mark Mayhew from Treehill Partners to discuss the latest dealmaking data, the pipeline pitfalls to avoid, and more.

Watch the webinar.

Evaluate and Treehill Partners discuss the state of play and look for smart ways to get investment and deals moving as we head into 2023.

View the webinar to get insights on:

  • The latest IPO, M&A, and share price data
  • How a changing ecosystem requires innovative intervention
  • Optimal deal structures
  • The importance of good preparation and due diligence

Cem Baydar, Ph.D

Chief Consulting Officer, Evaluate


Paul Verdin

VP, Head of Consulting & Analytics, Evaluate